Your gift is 100% tax deductible
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Live Chat available weekdays, 7:00 am - 6:30 pm CT
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Every donation counts.
Your gift helps fund crucial, lifesaving research and support for
those facing breast cancer.
The amount must be greater than or equal to $5
Your gift is 100% tax deductible
If you or your child is diagnosed with Hodgkin lymphoma, your cancer care team will try to figure out if it has spread, and if so, how far. This process is called staging.
The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
Hodgkin lymphoma generally starts in the lymph nodes. If it spreads, it is usually to another set of nearby lymph nodes. It can also invade (grow into) nearby organs. Rarely, Hodgkin lymphoma starts in an organ other than lymph nodes, such as a lung.
Your Hodgkin lymphoma stage is based on:
In general, imaging tests such as PET and CT scans play the biggest role in determining the stage of Hodgkin lymphoma. You can learn more about these exams, tests, and biopsies in Tests for Hodgkin Lymphoma.
The staging system used for Hodgkin lymphoma is the Lugano classification, which is based on the older Ann Arbor system. A staging system is a way for the cancer care team to sum up the extent of a cancer’s spread.
How to read this information
Cancer staging can be complex, so ask your doctor to explain it in a way you understand.
Either of the following means that the Hodgkin lymphoma is stage I:
Either of the following means that the Hodgkin lymphoma is stage II:
Either of the following means that the Hodgkin lymphoma is stage III:
Other modifiers may also be used to describe the Hodgkin lymphoma stage:
Bulky disease is usually labeled by adding the letter X to the stage. It describes:
This is especially important for stage II lymphomas, because bulky disease may require more intensive treatment.
Each stage may also be assigned a letter (A or B). For example: IIIB.
B is added if a person has any of these B symptoms:
If a person has any B symptoms, it usually means the lymphoma is more advanced and more intensive treatment is often recommended.
A is added to the stage if no B symptoms are present.
Resistant or recurrent Hodgkin lymphoma is not part of the formal staging system, but your cancer care team might use these terms to describe what's going on with the lymphoma in some cases.
Resistant or progressive disease: These terms are used when the lymphoma doesn’t go away or progresses (grows) while you're being treated.
Recurrent or relapsed disease: These terms mean Hodgkin lymphoma went away with treatment, but it has now come back. If the lymphoma returns, it might be in the same place it started or in another part of the body. This can happen shortly after treatment or years later.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
American Joint Committee on Cancer. Hodgkin and Non-Hodgkin Lymphoma. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 937.
Bartlett NL, Foyil KV. Chapter 105: Hodgkin lymphoma. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.
Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol. 2014;32:3059-3068.
National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Hodgkin Lymphoma, Version 2.2025 -- Jan 30, 2025. Accessed at www.nccn.org/professionals/physician_gls/pdf/hodgkins.pdf on July 10, 2025.
Younes A, Carbone A, Johnson P, Dabaja B, Ansell S, Kuruvilla J. Chapter 102: Hodgkin’s lymphoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.
Last Revised: October 6, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.